SMAD4 and pancreatic neoplasm: On the other hand, one previous report has shown that the percentage of overall inactivation or loss of SMAD4 in pancreatic cancer is 60%–90% (Moustakas and Heldin, 2005) and our result (74.1%) is within the range.